Company Valuation: Neochim AD

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 67.25 58.44 105.5 63.36 69.99 54.4
Change - -13.1% 80.54% -39.95% 10.47% -22.27%
Enterprise Value (EV) 1 55.02 -10.39 3.66 49.99 32.94 0.1717
Change - -118.88% 135.23% 1,265.7% -34.11% -99.48%
P/E 4.5x 1.25x 1.51x -1.78x -18.6x 6.51x
PBR 0.7x 0.41x 0.53x 0.42x 0.47x 0.35x
PEG - 0x 0x 0x 0.2x -0x
Capitalization / Revenue 0.3x 0.17x 0.17x 0.22x 0.26x 0.15x
EV / Revenue 0.25x -0.03x 0.01x 0.17x 0.12x 0x
EV / EBITDA 1.99x -0.16x 0.04x -1.57x 9.54x 0.04x
EV / EBIT 3.2x -0.19x 0.05x -1.22x -6.8x -0.05x
EV / FCF 2.17x -0.24x 0.15x -0.82x 1.04x 0.03x
FCF Yield 46.1% -413% 667% -123% 96.4% 3,763%
Dividend per Share 2 0.4 5 5 - - 3.91
Rate of return 1.54% 22.1% 12.3% - - 18.6%
EPS 2 5.777 18.04 27.09 -13.74 -1.45 3.226
Distribution rate 6.92% 27.7% 18.5% - - 121%
Net sales 1 221.4 352.2 629.5 293.9 273.3 357.7
EBITDA 1 27.63 63.64 88.47 -31.88 3.454 4.816
EBIT 1 17.17 53.36 78.55 -40.85 -4.841 -3.728
Net income 1 14.94 46.65 70.04 -35.54 -3.755 8.342
Net Debt 1 -12.23 -68.83 -101.8 -13.37 -37.05 -54.23
Reference price 2 26.00 22.60 40.80 24.46 27.00 21.00
Nbr of stocks (in thousands) 2,586 2,586 2,586 2,586 2,586 2,586
Announcement Date 2/25/21 A 4/29/22 A 4/26/23 A 4/26/24 A 2/26/25 A 4/28/26 A
1BGN in Million2BGN
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 41.23M
16.39x1.6x7.11x3.04% 34.15B
10.67x3.4x5.94x3.73% 17.7B
7.97x2.25x4.65x1.86% 17.9B
19.92x3.77x13.03x6.06% 14.42B
8.69x0.84x4.67x5.93% 10.79B
14.76x0.95x4.69x - 8.12B
Average 13.07x 2.14x 6.68x 4.12% 15B
Weighted average by Cap. 13.50x 2.20x 6.86x 3.73%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Neochim AD

Historical PBR trend

Valuation ratios - PBR - Neochim AD

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Neochim AD

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Neochim AD

  1. Stock Market
  2. Stocks
  3. NEOH Stock
  4. Valuation Neochim AD